CURRICULUM VITAE Sunil V. Rao, MD FACC - TransradialWorld

CURRICULUM VITAE
Sunil V. Rao, MD FACC FSCAI
Current Positions: Assistant Professor of Medicine, Duke University
Medical Center
Director, Cardiac Catheterization Laboratories
Durham Veterans Affairs Medical Center
Durham, North Carolina
Contact Information:
Home 105 Graylyn Drive
Chapel Hill, NC 27516
919-968-4278
Office Durham VA Medical Center
508 Fulton Street (111A)
Room A3023
Durham, NC 27705
Phone 919-684-8111
Fax 919-286-6821
Pager 919-970-2393
Email sunil.rao@duke.edu
Date and Place of birth:
March 23, 1971
New York, New York
USA
Marital Status:
Married, wife Caroline Hebert Rao MD
Staff Dermatologist
Durham VA Medical Center
Durham, North Carolina
Children:
Licensure:
Maya, born 2/27/1999
Lillian, born 3/19/2001
Ava, born 10/16/2003
Grace, born 8/31/2006
North Carolina Medical Board
Page 1 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

License number: 9900329
Issued: March 1999
Board Certification:
Board certification in Internal Medine 1999
Medical Training:
Education:
Board certification in Cardiovascular Disease 2005
Board Certification in Interventional Cardiology 2007
Warren S. & Gloria R. Newman Fellow in Interventional
Cardiology
Division of Cardiology
Duke University Medical Center
2003-2004
Cardiology Fellow
Division of Cardiology
Duke University Medical Center
1999-2003
Chief Fellow, Cardiology
Division of Cardiology
Duke University Medical Center
2001-2002
Resident, Internal Medicine
Department of Internal Medicine
Duke University Medical Center
1997-1999
Intern, Internal Medicine
Department of Internal Medicine
Duke University Medical Center
1996-1997
Doctor of Medicine (M.D.), 1996
The Ohio State University College of Medicine
Columbus, Ohio
Page 2 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

Bachelor of Arts, Zoology (B.A.), 1992
Miami University
Oxford, Ohio
Honors and Awards:
Duke University Medical Center
• Warren S. & Gloria R. Newman Fellowship in Interventional
Cardiology
• Outstanding Senior Resident Talk – “Ventricular Tachycardia”
1999
• Senior Resident Research Presentation, Medical Grand Rounds
– “Patterns of Use of Stress Testing in Unstable Angina/Non Q-
Wave MI: Insights from GUSTO IIa,” 1999
• Finalist, Resident Mentor Award, 2008
The Ohio State University Medical Center
• Graduated Magna Cum Laude 1996
• The David Saylor Memorial Award for Cardiology Research
1996
• Honors, Lecture-discussion curriculum 1993-1994
• The James W. Thurber Fellowship for Research in
Ophthalmology 1993
• Honors, Gross anatomy and embryology 1992-1993
• Honors, Cell & tissue biology 1992-1993
• Honors, Neuroscience 1992-1993
Miami University
• Graduated Summa Cum Laude and With Honors (GPA 3.97)
1992
• President’s List (4.0 GPA) 7 of 8 semesters
• Dean’s List (3.5-3.9 GPA) 1 semester
Honor Societies:
The Ohio State University College of Medicine
• Alpha Omega Alpha, Gamma chapter 1996
• The American Pathology Chairpersons Pathology Honor Society
1993
Miami University
• Phi Beta Kappa 1992
• Phi Kappa Phi 1991
National professional society membership
Page 3 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

• Member, American College of Cardiology Scientific Sessions
planning committee 2007-2010
• Faculty, Transcatheter Cardiovascular Therapeutics (TCT)
Annual conference 2005-present
• Faculty, Transcatheter Cardiovascular Therapeutics Annual
Interventional Fellows’ Course, 2007-present
• Fellow, American College of Cardiology
• Fellow, Society for Cardiac Angiography and Interventions
Editorial board memberships
• Associate editor, The American Heart Journal
Ongoing Research Support
• HHS-N-260-2005-00010-C
o NIH/NIA
o 9/30/2005 – present
o Title and goal: Reduction in Infarct Expansion and
Ventricular Remodeling with Erythropoietin After Large
Myocardial Infarction (REVEAL); a phase II randomized
trial of intravenous erythropoietin after successful primary
or rescue PCI
o Role: Co-Investigator
• American College of Cardiology
o 6/2006 – present
o Title: ACC National Cardiovascular Data Registry
o Role: Co-Investigator
• Cordis Corporation
o 11/2006 – present
o Title: Accessing Chronic Total Occlusions with the
Sirolimus Stent (ACROSS) Study
o Role: National Principal Investigator
• Population Health Research Institute (McMaster University)
o 1/2009-present
o Title: FUTURA Trial
o Role: US National Coordinator, Steering Committee
member
Page 4 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

• Portola Pharmaceuticals
o 6/2008 – present
o Title: A Randomized, Double-Blind, Active-Controlled
Trial to Evaluate Intravenous and Oral PRT060128, a
Selective and Reversible P2Y12-Receptor Inhibitor, vs.
Clopidogrel, as a Novel Antiplatelet Therapy in Patients
Undergoing Non-Urgent Percutaneous Coronary
Interventions (INNOVATE-PCI)
o Role: National Principal Investigator
Abstracts, Posters, and Presentations:
“Elevated cardiac markers across a spectrum of patients with chest pain:
Defining the role of isolated troponin or CKMB elevation.” November 14, 2001.
Anaheim, California. Oral presentation at the American Heart Association 2001
Scientific Sessions.
“Poverty, Process of care, and Outcomes in Acute Coronary Syndromes.” March
17, 2002. Atlanta, Georgia. Poster presented as part of the American College of
Cardiology 51 st Annual Scientific Sessions.
“Bleeding Among Patients with Acute Coronary Syndromes is Associated with a
Higher Risk of Short- and Long-term Death.” November 9, 2004. New Orleans,
Louisiana. Poster presented as part of the American Heart Association 2004
Scientific Sessions.
“On- versus Off-label Use of Drug-Eluting Stents in Clinical Practice: Data from
the American College of Cardiology-National Cardiovascular Disease Registry.”
November 10, 2004. New Orleans, Louisiana. Oral presentation at the
American Heart Association 2004 Scientific Sessions.
“Predictors of Drug-Eluting Stent Use in Clinical Practice: A Report from the
American College of Cardiology-National Cardiovascular Disease Registry.”
November 10, 2004. New Orleans, Louisiana. Oral presentation at the
American Heart Association 2004 Scientific Sessions.
“Predictors of major bleeding and transfusion in the SYNERGY trial: Effect of
pretreatment variables and treatment assignment.” March 9, 2005. Orlando,
Florida. Oral presentation at the American College of Cardiology 2005 Scientific
Sessions.
“Bleeding and blood transfusion rates are higher among acute coronary
syndrome patients in the United States than in other countries.” November 15,
2005. Dallas, Texas. Poster presentation at the American Heart Association
2005 Scientific Sessions.
Page 5 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

“Revascularization improves survival compared with medical therapy among
patients with rheumatologic disease and coronary artery disease.” November 14,
2006. Chicago, Illinois. Poster presentation at the American Heart Association
2006 Scientific Sessions.
“The radial approach to percutaneous coronary intervention is associated with a
lower risk for complications regardless of radial procedure volume: A report from
the American College of Cardiology National Cardiovascular Data Registry.”
March 25, 2007. New Orleans, LA. E-Poster presentation at the American
College of Cardiology 2007 Scientific Sessions.
“Bleeding and blood transfusion are major drivers of cost among patients with
acute coronary syndromes.” March 27, 2007. New Orleans, LA. Oral
presentation at the American College of Cardiology 2007 Scientific Sessions.
“Incidence and short-term outcomes of drug-eluting stent fracture in chronic total
occlusions: An analysis from the ACROSS-Cypher Trial.” Chicago, IL. Oral
presentation at the American College of Cardiology 2008 Scientific Sessions.
“Clinical and angiographic outcomes with sirolimus-eluting stents in total
coronary occlusions: ACROSS/TOSCA-4 Trial.” Chicago, IL. Oral presentation
at the American College of Cardiology 2008 Scientific Sessions.
“Lack of impact of randomized trials on percutaneous coronary intervention
practice: Data from the National Cardiovascular Data Registry.” Chicago, IL.
Oral presentation at the American College of Cardiology 2008 Scientific
Sessions.
“Annual case volume is not a strong predictor of bleeding after percutaneous
coronary intervention: A report from the National Cardiovascular Data Registy.”
Orlando, FL. Poster presentation at the American College of Cardiology 2009
Scientific Sessions.
“Evaluation of M118 in Percutaneous Coronary Intervention: First results of the
Phase 2 EMINENCE Trial.” San Francisco, CA. Oral presentation at the
Transcatheter Cardiovascular Therapeutics Conference 2009.
“Comparative effectiveness of radial and femoral approaches to percutaneous
coronary intervention on long-term mortality: A report from the NHLBI Dynamic
Registry.” Atlanta, GA. Poster presentation at the American College of
Cardiology 2010 Scientific Sessions.
Publications:
Journal articles
Page 6 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

1. Cuffe MS, Rao S, O'Connor CM. Heart failure and special therapeutic
considerations in older patients. Clinical Geriatrics 1997;5(3):56-71.
2. Rao SV, Bethel MA, Feinglos MN. Treatment of diabetes mellitus:
implications of the use of oral agents. American Heart Journal 1999;138(5
Pt 1):S334-7.
3. Rao SV, Jollis JG. Reperfusion for acute myocardial infarction: Is the
future in plastics? Mayo Clinic Proceedings 2000;75:991-993.
4. Rao SV, Donahue M, Pi-Sunyer FX, Fuster V. Obesity as a risk factor for
coronary artery disease. American Heart Journal 2001;142(6):1102-1107.
5. Rao SV, Jollis JG. Quality of care in percutaneous coronary intervention.
Cardiovascular Reviews and Reports. March 2002, 165-173.
6. Rao SV, Stamler JS. Erythropoietin, anemia, and orthostatic hypotension:
the evidence mounts… Clinical Autonomic Research 2002;12:141-143.
7. Rao SV, Califf RM. Lessons learned from clinical trials: A roundtable
discussion. Critical Pathways in Cardiology 2003;2:55-59.
8. Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB,
Christenson RH, Hasselblad V, Stebbins A, McNulty S, Newby LK.
Prognostic value of isolated troponin elevation across the spectrum of
chest pain syndromes. The American Journal of Cardiology
2003;91(8):936-940.
9. Rao SV, Kaul P, Newby LK, Lincoff AM, Hochman J, Harrington RA, Mark
DB, Peterson ED. Poverty, process of care, and outcome in acute
coronary syndromes. Journal of the American College of Cardiology
2003;41(11):1948-1954.
10. Rao SV, Jollis JG, Sketch MH Jr. Assessing quality in the cardiac
catheterization laboratory. The American Heart Hospital Journal
2003;1(4):289-296.
11. Wilmer WA, Rovin BH, Hebert CJ, Rao SV, Kumor K, Hebert LA.
Management of glomerular proteinuria: A commentary. Journal of the
American Society of Nephrology 2003;14:3217-3232.
12. Rao SV. Controversies surrounding the use of glycoprotein IIb/IIIa
inhibitors. Critical Pathways in Cardiology 2003;2(4):231-238.
Page 7 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

13. Rao SV, Schulman KA, Curtis LH, Gersh BJ, Jollis JG. Socioeconomic
status and outcome after acute myocardial infarction in the elderly.
Archives of Internal Medicine 2004;164:1128-1133.
14. Patel MR, Meine TJ, Radeva J, Curtis L, Rao SV, Schulman KA, Jollis JG.
State-mandated continuing medical education and the use of proven
therapies in patients with an acute myocardial infarction. Journal of the
American College of Cardiology 2004;44:192-198.
15. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PA,
Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. The
relationship of blood transfusion and clinical outcomes in patients with
acute coronary syndromes. JAMA 2004;292:1555-1562.
16. Asher CR, Moliterno DJ, Bhapkar MV, McGuire DK, Rao SV, Holmes DR,
Newby K, Bates ER, Topol EJ. Association of race with complications and
prognosis following acute coronary syndromes. The American Journal of
Cardiology 2004;94(6):792-794.
17. Turer AT, Rao SV. Device therapy in the management of congestive
heart failure. Cardiology in Review 2005;13(3):130-138.
18. Meine TJ, Patel MR, DePuy V, Curtis LH, Rao SV, Gersh BJ, Schulman
KA, Jollis JG. Evidence-based therapies and mortality in patients
hospitalized in December with acute myocardial infarction. Annals of
Internal Medicine 2005;143:481-485.
19. Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao SV, Gibler
WB, Ohman EM, Peterson ED. The implications of blood transfusions for
patients with non-ST-segment elevation acute coronary syndromes:
Results from the CRUSADE National Quality Improvement Initiative.
Journal of the American College of Cardiology 2005;46:1490-1495.
20. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F,
Mahaffey KW, Califf RM, Harrington RA. The impact of bleeding severity
on clinical outcomes among patients with acute coronary syndromes. The
American Journal of Cardiology 2005;96:1200-1206.
21. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW,
Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RA,
Harrington RA. A comparison of the clinical impact of bleeding measured
by two different classifications among patients with acute coronary
syndromes. Journal of the American College of Cardiology 2006;47:809-
816.
Page 8 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

22. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating,
and prothrombotic properties of anemia and blood product transfusion.
Journal of Thrombosis and Thrombolysis 2006;21(2):167-174.
23. Rao SV, Shaw RE, Brindis RG, Klein LW, Weintraub WW, Peterson ED.
On- vs. Off-label use of drug-eluting coronary stents in clinical practice
(Report from the American College of Cardiology National Cardiovascular
Data Registry [NCDR]). The American Journal of Cardiology 2006;
97(10): 1478-81.
24. Rao SV, Shaw RE, Brindis RG, Klein LW, Weintraub WS, Krone RJ,
Peterson ED. Patterns and outcomes of drug-eluting coronary stent use
in clinical practice. American Heart Journal 2006;152:321-326.
25. Rao SV, Honeycutt EF, Kandzari DE. Clinical outcomes with drug-eluting
stents following atheroablation therapies. Journal of Invasive Cardiology
2006;18:393-396.
26. Cohen M, Diez J, Fry E, Rao SV, Ferguson JJ 3 rd , Zidar J, Levine G,
Shani J. Strategies for optimizing outcomes in the NSTE-ACS patient The
CATH (cardiac catheterization and antithrombotic therapy in the hospital)
Clinical Consensus Panel Report. Journal of Invasive Cardiology
2006;18(12):617-39.
27. Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand
JP. Bleeding and blood transfusion issues among patients with non STsegment
elevation acute coronary syndromes. European Heart Journal
2007;28:1193-1204.
28. Wallace TW, Rao SV. The challenge of defining bleeding among patients
with acute coronary syndromes. Clinical Cardiology 2007;30(S2):II16-II23.
29. Wang TY, Rao SV. Anemia in patients undergoing percutaneous coronary
intervention: current issues and future directions. American Journal of
Cardiovascular Drugs 2007;7:225-33.
30. Rao SV, Chiswell K, Sun JL, Granger CB, Newby LK, van de Werf F,
White HD, Armstrong PW, Califf RM, Harrington RA. International
variation in the use of blood transfusion among patient with non-STsegment
elevation acute coronary syndromes. The American Journal of
Cardiology 2008;101:25-29.
31. Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf
RM, Harrington RA, Eisenstein EL, Mark DB. Association between
bleeding, blood transfusion, and costs among patients with non ST-
Page 9 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

segment elevation acute coronary syndromes. American Heart Journal
2008;155:369-374.
32. Mehta RH, Rao SV, Ohman EM, Bates ER, Marcucci G, Zhang M, Pieper
KS, Armstrong PW, White HD, Van de Werf F, Califf RM, Granger CB.
Variation in the use of stress testing and outcomes in patients with non
ST-segment elevation acute coronary syndromes: Insights from GUSTO
IIb. European Heart Journal 2008;29:880-887.
33. Roberts WC, Granger CB, Patel MR, Rao SV, Sinnaeve PR, Sulkes DJ.
The Editor’s roundtable: Management and treatment of non-ST-segment
elevation acute coronary syndromes. The American Journal of Cardiology
2008;101:1580-1598.
34. Alexander KP, Chen AY, Wang TY, Rao SV, LaPointe NM, Ohman EM,
Roe MT, Boden WE, Harrington RA, Peterson ED. Transfusion practice
and outcomes in non-ST-segment elevation acute coronary syndromes.
American Heart Journal 2008;155:1047-1053.
35. Kleiman NS, Freedman JE, Tracy PB, Furie BC, Bray PF, Rao SV, Phillips
DR, Storey RF, Rusconi CP, French PA, Steinhubl SR, Becker RC.
Platelets: developmental biology, physiology, and translatable platforms
for preclinical investigation and drug development. Platelets 2008;19:239-
251.
36. Cavender MA, Rao SV, Ohman EM. Major bleeding: management and
risk reduction in acute coronary syndromes. Expert Opinion on
Pharmacotherapy 2008;9:1869-1883.
37. Rao SV, Califf RM, Kramer JM, Peterson Ed, Gross TP, Pepine CJ,
Williams DO, Donohoe D, Waksman R, Mehran R, Krucoff MW.
Postmarket evaluation of breakthrough technologies. The American Heart
Journal 2008;156:201-208.
38. Wang TY, Peterson ED, Dai D, Anderson HV, Rao SV, Brindis RG, Roe
MT. Patterns of cardiac marker surveillance after elective percutaneous
coronary intervention and implications for the use of periprocedural
myocardial infarction as a quality metric: A report from the National
Cardiovascular Data Registry. Journal of the American College of
Cardiology 2008;51:2068-2074.
39. Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED,
Rao SV, Matchar DB, Mark DB, Harrington RA, Eisenstein EL. Long-term
clinical outcomes following coronary stenting. Archives of Internal
Medicine 2008;168:1647-1655.
Page 10 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

40. Wang TY, Xiao L, Alexander KP, Rao SV, Kosiborod MN, Rumsfeld JS,
Spertus JA, Peterson ED. Antiplatelet therapy use after discharge among
acute myocardial infarction patients with in-hospital bleeding. Circulation
2008;118:2139-2145.
41. Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC,
Rao SV, Reilly RF, Brilakis ES. Comparison of the impact of short ( or =1 year) clopidogrel use following percutaneous
coronary intervention on mortality. American Journal of Cardiology
2008;102:1159-1162.
42. Kim JH, Newby LK, Clare RM, Shaw LK, Lodge AJ, Smith PK, Jolicoeur
EM, Rao SV, Becker RC, Mark DB, Granger CB. Clopidogrel use and
bleeding after coronary artery bypass graft surgery. American Heart
Journal 2008;156:886-892.
43. Cohen M, Alexander KP, Rao SV. Bleeding after antithrombotic therapy in
patients with acute ischemic heart disease: is it the drugs or how we use
them? Journal of Thrombosis & Thrombolysis 2008;26:175-82.
44. Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson
ED. Trends in the prevalence and outcomes of the radial and femoral
approaches to percutaneous coronary intervention. JACC: Cardiovascular
Interventions 2008;1:379-386.
45. Rao SV, Kim SYH. Informing the consent process. Circulation:
Healthcare Quality and Outcomes 2008;1:7-8.
46. Happe LE, Rao SV, Horblyuk R, Franklin M, Lunacsek OE, Menditto L.
Consequences of major bleeding in hospitalized patients with non-ST
segment elevation acute coronary syndromes receiving injectable
anticoagulants. Current Medical Research & Opinion 2009;25:413-420.
47. Maynard C, Rao SV, Gregg M, Phillips RC, Reisman M, Tucker E, Goss
JR. The role of out-of-hospital cardiac arrest in predicting hospital mortality
for percutaneous coronary interventions in the Clinical Outcomes
Assessment Program. Journal of Invasive Cardiology 2009;21:1-5.
48. Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ,
Simonton CA, Garg J, Lokhnygina Y, Mancini GBJ, Yeoh E, Buller CE, for
the ACROSS/TOSCA-4 Investigators. Clinical and Angiographic
Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions:
The ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With
Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4)
Trial. JACC: Cardiovascular Interventions 2009;2:97-106.
Page 11 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

49. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang
TY, Gibler WB, Ohman EM, Roe MT, Pollack CV Jr., Peterson ED,
Alexander KP. Baseline risk of major bleeding in non-ST-segmentelevation
myocardial infarction: the CRUSADE (Can Rapid risk
stratification of Unstable angina patients Suppress ADverse outcomes
with Early implementation of the ACC/AHA Guidelines) Bleeding Score.
Circulation 2009;119:1873-1882.
50. Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou
FS, Roe MT, Peterson ED, Marso SP. Bleeding in patients undergoing
percutaneous coronary intervention: the development of a clinical risk
algorithm from the National Cardiovascular Data Regsitry. Circulation:
Cardiovascular Interventions 2009;2:222-229.
51. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS,
Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct
artery intervention during primary percutaneous coronary intervention for
ST-segment elevation myocardial infarction (from the National
Cardiovascular Data Registry). American Journal of Cardiology
2009;104:507-513.
52. Povsic TJ, Adams SD, Zavodni KL, Kelly F, Melton LG, Rao SV, Najjar
SS, Harrington RA, Peterson ED. Aldehyde dehydrogenase activity
allows reliable EPC enumeration in stored peripheral blood samples.
Journal of Thrombosis & Thrombolysis 2009;28:259-265.
53. Melloni C, Fier I, Roach J, Kosinski AS, Broderick S, Sigmon K, Myles S,
Becker RC, Rao SV on behalf of the EMINENCE Investigators. Design
and rationale of the Evaluation of M118 IN pErcutaNeous Coronary
intErvention (EMINENCE) Trial. American Heart Journal 2009;158:726-
733.
54. Rao SV. Using procedural approaches to reduce complications related to
percutaneous coronary interventions. Journal of Invasive Cardiology
2009;21 (8 Suppl A):21A-24A.
55. Vavalle JP, Rao SV. The association between the transradial approach for
percutaneous coronary interventions and bleeding. Journal of Invasive
Cardiology 2009;21(8 Suppl A):21A-24A.
56. Rao SV. Strategies to reduce bleeding among patients with ischemic
heart disease treated with antiplatelet therapies. American Journal of
Cardiology 2009;104(5 suppl):60C-63C.
57. Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP,
Rao AK, Gibson CM, Petersen JL, Mehran R, Manoukian SV, Charnigo R,
Page 12 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

Lee KL, Moscucci M, Harrington RA on behalf of the Academic Bleeding
Consensus Multidisciplinary Working Group. Standardized reporting of
bleeding complications for clinical investigations in acute coronary
syndromes: a proposal from the academic bleeding consensus
(ABC) multidisciplinary working group. American Heart Journal
2009;158:881-886.
58. Rao SV, Ohman EM. Anticoagulant therapy for percutaneous coronary
intervention. Ciruclation: Cardiovascular Interventions 2010;3:80-88.
59. Rao SV, Melloni C, Myles-DiMauro S, Broderick S, Kosinski AS, Kleiman
NS, Dzavik V, Tanguay JF, Chandna H, Gammon R, Rivera E, Alexander
JH, Fier I, Roach J, Becker RC. Evaluation of a new heparin agent in
percutaneous coronary intervention: Results of the Phase 2 Evaluation of
M118 IN pErcutaNeous Coronary intervention (EMINENCE) trial.
Circulation 2010;121:1713-1721.
60. Rao SV, Cohen MG, Kandzari DH, Bertrand OF, Gilchrist IC. The
transradial approach to percutaneous coronary intervention: Historical
perspective, current concepts, and future directions. JACC (in press).
61. Rao SV, Califf RM. Is old blood bad blood? American Heart Journal (in
press).
62. Rao SV. Scaling new heights in quality improvement. JACC 2010 (in
press).
Book chapters
1. McGuire DK, Rao SV. Epidemiology of Diabetes and Cardiovascular
Disease. In: The Handbook of Diabetes and Cardiovascular Disease.
Steven P. Marso, editor. Remedica Publishing, London UK, 2003.
2. Rao SV, McGuire DK. Epidemiology of Diabetes and Cardiovascular
Disease. In: Diabetes and Cardiovascular Disease. Steven P. Marso MD,
Alan Stern MD, editors.
3. Rao SV, Newby LK. Risk stratification in acute coronary syndromes. In:
The Year In Interventional Cardiology 2003. Clinical Publishing Ltd.,
Oxford UK, 2003.
4. Rao SV, Newby LK. Risk stratification in acute coronary syndromes. In:
The Year In Interventional Cardiology 2004. Clinical Publishing Ltd.,
Oxford UK, 2004.
Page 13 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010

5. Rao SV, Zidar FJ, Zidar JP. Iliac angioplasty and stenting. In:
Interventional Cardiology. McGraw-Hill Publishing. Spencer B. King III
MD, Alan C. Yeung MD, editors.
Alternative media
Host, Duke Clinical Medicine Series. “Cardiovascular Cath Lab Conference”
available at http://cathlabconference.dcri.duke.edu; 2006 - present
Rao SV. Day in Review: American College of Cardiology Annual Scientific
Sessions 2004. www.theheart.org
Rao SV. Day in Review: American College of Cardiology Annual Scientific
Sessions 2003. www.theheart.org
Rao SV. Day in Review: American Heart Association Scientific Sessions 2002.
www.theheart.org
Rao SV. Day in Review: American College of Cardiology Annual Scientific
Sessions 2002. www.theheart.org
Rao S. Commentary: Review of the ESPRIT Trial. MD Consult Cardiology 2002.
http://www.mdconsult.com
Rao SV. Day in Review: American Heart Association Scientific Sessions 2001.
www.theheart.org
Page 14 of 14 Curriculum Vitae, Sunil V. Rao
5/1/2010